Logo
Exxaro Resources Limited
Annual Financial Statements 2022
1Chapter
2Chapter
3Chapter
4Chapter
5Chapter
6Chapter
7Chapter
8Chapter
9Chapter
10Chapter
<Next
11Chapter
12Chapter
13Chapter
14Chapter
15Chapter
16Chapter
17Chapter
18Chapter
19Chapter
>Previous

CHAPTER 14:People

  • 14.5 DIRECTORS' AND PRESCRIBED OFFICERS' REMUNERATION
  • 14.5.1 Remuneration policy

The remuneration committee has a defined mandate from the board of directors aimed at:

  • Ensuring that the chairman, directors and senior executives are fairly rewarded for their individual contributions to the group's overall performance
  • Ensuring that the remuneration strategies and packages, including the incentive schemes, are related to performance, are suitably competitive and give due regard to the interests of the shareholders and the financial and commercial health of the group.
  • 14.5.2 Summary of remuneration
NCOE/guaranteed remuneration plus circumstantial Short term incentives Long term incentives
2022 Basic salary
R
Benefits and  
allowances1
R  
Retirement fund
contributions
R
Performance  
bonuses2
R  
Gains on
management
share schemes
R
Executive directors
MDM Mgojo7 4 243 282 172 857 404 151 4 047 137 56 866 749
Dr N Tsengwa 6 724 009 261 271 562 520 7 866 142 7 715 608
PA Koppeschaar 5 651 855 190 830 476 590 5 307 320 10 272 043
Total executive directors' remuneration 16 619 146 624 958 1 443 261 17 220 599 74 854 400
Prescribed officers
V Balgobind8 3 006 820 111 975 243 738   4 474 598
H Bhola9 2 214 142 130 034 210 588 1 414 817 2 024 471
AS De Angelis 3 136 377 71 341 227 210 1 765 318 1 433 425
L Groenewald10 3 210 129 229 515 312 735 2 301 752 4 148 534
PK Masia11 4 018 803   336 207 3 494 746  
JG Meyer 3 801 032 336 323 378 638 3 070 151 2 361 193
MI Mthenjane 3 837 510 98 234 321 040 2 834 229 4 006 111
AT Ndoni 2 446 471 51 445 177 231 1 484 294  
R Tatnall12 3 466 249 959 176   4 586 396  
M Veti 3 833 931   364 647 2 845 857 4 390 385
Total prescribed officers' remuneration 32 971 464 1 988 043 2 572 034 23 797 560 22 838 717

Other              
2022  Exit   payment 
paid3
Recognition4
Other5
R
 
Total
remuneration 
Share-based 
payment 
expense6
R
 
Gains on 
management 
share schemes 
R
 
Total 
remuneration 
expense 
R
 
Executive directors 
MDM Mgojo7  8 424 684  6 260  225 220  74 390 340  3 860 458  (56 866 749) 21 384 049 
Dr N Tsengwa      6 260      23 135 810  6 919 965  (7 715 608) 22 340 167 
PA Koppeschaar      6 260      21 904 898  5 227 294  (10 272 043) 16 860 149 
Total executive directors' remuneration  8 424 684  18 780  225 220  119 431 048  16 007 717  (74 854 400) 60 584 365 
Prescribed officers 
V Balgobind8  1 238 828  6 260  279 121  9 361 340  (1 389 985) (4 474 598) 3 496 757 
H Bhola9      57 860      6 051 912  1 130 190  (2 024 471) 5 157 631 
AS De Angelis      6 260      6 639 931  1 898 044  (1 433 425) 7 104 550 
L Groenewald10      6 260  13 966  10 222 891  2 237 496  (4 148 534) 8 311 853 
PK Masia11              7 849 756  1 749 882      9 599 638 
JG Meyer      6 260      9 953 597  2 657 050  (2 361 193) 10 249 454 
MI Mthenjane      6 260  99 417  11 202 801  2 394 111  (4 006 111) 9 590 801 
AT Ndoni          722 290  4 881 731  687 842      5 569 573 
R Tatnall12  9 000 000      160 650  18 172 471          18 172 471 
M Veti      6 260      11 441 080  2 540 937  (4 390 385) 9 591 632 
Total prescribed officers' remuneration  10 238 828  95 420  1 275 444  95 777 510  13 905 567  (22 838 717) 86 844 360 
1 Includes leave days purchased as well as travel and acting allowances.
2 All incentive schemes are performance related and were approved by the board of directors.
3 Includes ex-gratia and mutual separation pay-outs.
4 Includes long service awards, zero-fatality and LTIFR rewards.
5 Includes leave encashments and retention allowances.
6 Amount recognised for share-based payment expenses, in terms of IFRS 2, in respect of equity-settled share-based payment schemes for services rendered during the year. The employee will only be entitled to the options once all vesting conditions have been met.
7 Retired on 31 July 2022.
8 Resigned on 30 November 2022.
9 Appointed as acting executive head: human resources on 13 September 2022. Remuneration information relates to the full year.
10 Appointed as acting managing director: energy on 16 August 2022. Remuneration information relates to the full year.
11 Appointed as managing director: minerals on 1 March 2022.
12 Resigned on 31 August 2022.
13 Appointed on 7 February 2022.
14 Retired on 25 May 2022.

2022 Fees for
services
R
Benefits and  
allowances1
R  
Fees for
services
rendered to
subsidiaries
R
Total
R
Non-executive directors
Dr GJ Fraser-Moleketi 1 341 322     1 341 322
K Ireton13 550 142     550 142
B Magara13 550 577     550 577
B Mawasha13 655 316     655 316
IN Malevu 629 194     629 194
L Mbatha 652 318   88 136 740 454
Dr P Mnganga13 662 442     662 442
VZ Mntambo 652 754   116 696 769 450
LI Mophatlane 1 217 826 3 253   1 221 079
MLB Msimang 848 293     848 293
EJ Myburgh14 527 452     527 452
V Nkonyeni 1 067 868     1 067 868
CJ Nxumalo 1 028 084     1 028 084
MG Qhena (Chairman) 2 198 914 22 168   2 221 082
PCCH Snyders 1 177 614     1 177 614
Total non-executive directors' remuneration 13 760 116 25 421 204 832 13 990 369
1 Travelling reimbursement for visiting the various operations of the company during the year.

Retirement amounts relate to defined contribution retirement funds.


NCOE/guaranteed remuneration plus circumstantial Short term incentives Long term incentives
2021 Basic salary
R
Benefits and  
allowances1
R  
Retirement fund
contributions
R
Performance  
bonuses2
R  
Gains on
management
share schemes
R
Executive directors
MDM Mgojo 6 947 131 291 500 662 456 4 079 336 22 856 637
Dr N Tsengwa6 5 366 990 211 657 449 202 2 840 928 7 241 197
PA Koppeschaar 5 235 563 301 917 460 447 3 018 760 9 441 112
Total executive directors' remuneration 17 549 684 805 074 1 572 105 9 939 024 39 538 946
Prescribed officers
V Balgobind 3 204 409 60 225 244 952 1 520 708 4 526 565
AS De Angelis 2 986 668 60 442 216 365 1 414 066 4 214 814
JG Meyer 3 624 697 329 399 361 866 1 870 110 4 862 538
MI Mthenjane 3 667 531 93 883 306 820 1 762 768 5 324 051
AT Ndoni7 415 740 30 118 81 726
R Tatnall8 4 548 281 1 108 848
SE van Loggerenberg9 292 895 11 180 18 900
M Veti 3 664 113 348 495 1 738 666 5 308 035
Total prescribed officers' remuneration 22 404 334 1 663 977 1 527 516 8 388 044 24 236 003

Other              
2021  Exit payment
paid
R
Recognition3
R  
Other4
R  
Total
remuneration
R
Share-based  
payment  
expense5
R  
Gains on
management
share schemes 
Total
remuneration
expense
R
 
Executive directors 
MDM Mgojo  49 760  130 722  35 017 542  13 350 626  (22 856 637) 25 511 531 
Dr N Tsengwa6  5 760  16 115 734  5 592 894  (7 241 197) 14 467 431 
PA Koppeschaar  7 760  18 465 559  6 131 435  (9 441 112) 15 155 882 
Total executive directors' remuneration  63 280  130 722  69 598 835  25 074 955  (39 538 946) 55 134 844 
Prescribed officers 
V Balgobind  5 760  16 336  9 578 955  2 617 682  (4 526 565) 7 670 072 
AS De Angelis  5 760  8 898 115  1 846 234  (4 214 814) 6 529 535 
JG Meyer  5 760  11 054 370  3 057 715  (4 862 538) 9 249 547 
MI Mthenjane  9 460  44 974  11 209 487  2 807 310  (5 324 051) 8 692 746 
AT Ndoni7  700 000  1 227 584  63 025  1 290 609 
R Tatnall8  5 657 129  5 657 129 
SE van Loggerenberg9  2 437 970  37 970  2 798 915  (850 361) 1 948 554 
M Veti  5 760  11 065 069  2 998 662  (5 308 035) 8 755 696 
Total prescribed officers' remuneration  2 437 970  32 500  799 280  61 489 624  12 540 267  (24 236 003) 49 793 888 

2021 Fees for
services
R
Fees for
services
rendered to subsidiaries
R
Total
R
Non-executive directors
Dr GJ Fraser-Moleketi 1 348 895 1 348 895
IN Malevu10 264 307 264 307
L Mbatha 667 102 61 184 728 286
VZ Mntambo 694 100 108 012 802 112
MJ Moffett11 306 340 188 100 494 440
LI Mophatlane 923 897 46 234 970 131
MLB Msimang12 438 671 438 671
EJ Myburgh 1 217 809 1 217 809
V Nkonyeni 991 677 236 500 1 228 177
CJ Nxumalo13 616 741 616 741
MG Qhena (chairman)14 1 267 377 1 267 377
J van Rooyen15 878 214 878 214
PCCH Snyders 1 012 324 1 012 324
Total non-executive directors' remuneration 10 627 454 640 030 11 267 484
1 Includes leave days purchased as well as travel and acting allowances.
2 All incentive schemes are performance related and were approved by the board of directors.
3 Includes long service awards, zero-fatality and LTIFR rewards.
4 Includes leave encashments and retention allowances.
5 Amount recognised for share-based payment expenses, in terms of IFRS 2, in respect of equity-settled share-based payment schemes for services rendered during the year. The employee will only be entitled to the options once all vesting conditions have been met.
6 Appointed to the board of directors on 16 March 2021.
7 Appointed on 1 November 2021.
8 Appointed on 10 March 2021, in terms of a fixed term employment contract.
9 Resigned on 18 February 2021.
10 Appointed on 22 June 2021.
11 Resigned on 11 May 2021.
12 Appointed on 15 March 2021.
13 Appointed on 1 February 2021.
14 Appointed on 19 April 2021.
15 Retired on 27 May 2021.

Retirement amounts relate to defined contribution retirement funds.

  • 14.5.3 Interests in Exxaro shares

(i) Number of shares

2022   2021
Directors at 31 December Direct Indirect Direct Indirect
Beneficial interests
PA Koppeschaar 68 846 7 374 63 781 11 415
MDM Mgojo 112 496 4 705 162
VZ Mntambo 4 448 839 4 448 839
Dr N Tsengwa 100 361 3 777 78 710 6 491

(ii) Percentages (direct and indirect)

Directors at 31 December 2022
%
2021
%
PA Koppeschaar 0.02 0.02
MDM Mgojo 1.38
VZ Mntambo 1.27 1.27
Dr N Tsengwa 0.03 0.02

There have been no changes in the directors' interests in Exxaro shares between the end of the financial year 2022 and the date on which the annual financial statements were approved.

  • 14.5.4 Share options and restricted share awards

The following options and rights in shares in the company were exercised or are outstanding in favour of directors and prescribed officers of the company under the company's share option schemes:

Management share scheme – LTIP

2022  Rights  
held at  
31 December1
Number  
Exercisable 
period
 
Proceeds if  
exercisable at  
31 December2
R  
Pre-tax  
gain if  
exercisable at  
31 December2
R  
MSR  
election3
Number
  
Options 
exercised 
during the 
year Number 
Shares 
forfeited4
Number
  
Sale price/ 
market 
price 
R
 
Pre‑tax 
gain
R
 
Date 
exercised
 
Executive directors 
MDM Mgojo      01/04/2022              88 460  27 109  218.71  19 347 087  01/04/2022 
    01/04/2023              91 055  89 974  219.76  20 010 247  22/08/2022 
    01/04/2024              45 354  60 946  219.76  9 966 995  22/08/2022 
    01/04/2025              7 926  81 055  219.35  1 738 568  01/09/2022 
                232 795  259 084  51 062 897 
Dr N Tsengwa      01/04/2022              32 393  9 927  218.71  7 084 673  01/04/2022 
66 289  01/04/2023  14 405 263  14 405 263     
80 115  01/04/2024  17 409 791  17 409 791     
14 224  01/04/2025  3 091 017  3 091 017     
78 093  01/04/2025  16 970 390  16 970 390     
238 721  51 876 461  51 876 461      32 393  9 927  7 084 673 
PA Koppeschaar      01/04/2022              41 571  12 739  218.71  9 091 993  01/04/2022 
85 072  01/04/2023  18 486 996  18 486 996     
49 954  01/04/2024  10 855 504  10 855 504     
41 816  01/04/2025  9 087 035  9 087 035     
176 842  38 429 535  38 429 535      41 571  12 739  9 091 993 
Prescribed officers 
V Balgobind      01/04/2022              17 558  5 380  218.71  3 840 110  01/04/2022 
    01/04/2023                  35 930 
    01/04/2024                  20 503 
    01/04/2025                  17 163 
                17 558  78 976  3 840 110 
H Bhola      01/04/2022              8 340  2 555  218.71  1 824 041  01/04/2022 
17 065  01/04/2023  3 708 395  3 708 395     
10 447  01/04/2024  2 270 238  2 270 238     
8 828  01/04/2025  1 918 413  1 918 413     
36 340  7 897 046  7 897 046      8 340  2 555  1 824 041 
AS De Angelis      01/04/2022          1 638  6 554  2 510  218.71  1 433 425  01/04/2022 
33 410  01/04/2023  7 260 327  7 260 327     
19 066  01/04/2024  4 143 232  4 143 232     
15 960  01/04/2025  3 468 268  3 468 268     
68 436  14 871 827  14 871 827  1 638  6 554  2 510  1 433 425 
L Groenewald      01/04/2022              16 128  4 942  218.71  3 527 355  01/04/2022 
33 002  01/04/2023  7 171 665  7 171 665     
19 175  01/04/2024  4 166 919  4 166 919     
16 832  01/04/2025  3 657 762  3 657 762     
69 009  14 996 346  14 996 346      16 128  4 942  3 527 355 
PK Masia  34 170  01/04/2025  7 425 483  7 425 483 
34 170  01/04/2025  7 425 483  7 425 483 
68 340  14 850 966  14 850 966                 
JG Meyer      01/04/2022          10 796  10 796  6 617  218.71  2 361 193  01/04/2022 
44 185  01/04/2023  9 601 842  9 601 842 
25 214  01/04/2024  5 479 254  5 479 254 
21 107  01/04/2025  4 586 762  4 586 762 
90 506  19 667 858  19 667 858  10 796  10 796  6 617  2 361 193 
MI Mthenjane      01/04/2022          2 035  18 317  6 237  218.71  4 006 111  01/04/2022 
41 649  01/04/2023  9 050 744  9 050 744 
23 767  01/04/2024  5 164 807  5 164 807 
19 895  01/04/2025  4 323 382  4 323 382 
85 311  18 538 933  18 538 933  2 035  18 317  6 237  4 006 111 
AT Ndoni  12 165  01/11/2024  2 643 576  2 643 576 
9 296  01/04/2025  2 020 114  2 020 114 
21 461  4 663 690  4 663 690             
M Veti      01/04/2022              20 074  6 152  218.71  4 390 385  01/04/2022 
41 080  01/04/2023  8 927 095  8 927 095 
23 442  01/04/2024  5 094 181  5 094 181 
19 623  01/04/2025  4 264 274  4 264 274 
84 145  18 285 550  18 285 550      20 074  6 152  4 390 385 
1 Option strike price is nil.
2 Based on a share price of R217.31 which prevailed on 31 December 2022.
3 Election to transfer shares arising from the vested options to the MSR portfolio.
4 Shares forfeited due to performance conditions not being fully met.
2021  Rights 
held at 
31 December1
Number
 
Exercisable 
period
 
Proceeds if 
exercisable at 
31 December2
R
 
Pre-tax 
gain if 
exercisable at 
31 December2
R
 
Modification 
during 
the year 
Number
 
Options 
exercised 
during 
the year 
Number
 
Shares 
forfeited3
Number
  
Sale price/ 
market  price
R
 
Pre‑tax 
gain 
R
 
Date 
exercised
 
Executive directors 
MDM Mgojo  01/04/2021  107 989  53 985  177.96  19 217 722  15/04/2021 
01/04/2021  5 248  3 499  1 749  174.39  610 191  23/09/2021 
115 569  01/04/2022  17 667 033  17 667 033  3 627 
181 029  01/04/2023  27 673 903  27 673 903  5 682 
106 300  01/04/2024  16 250 081  16 250 081 
402 898  61 591 017  61 591 017  14 557  111 488  55 734  19 827 913 
Dr N Tsengwa  01/04/2021  39 177  19 585  177.96  6 971 939  15/04/2021 
01/04/2021  1 904  1 270  634  174.39  221 475  23/09/2021 
42 320  01/04/2022  6 469 458  6 469 458  1 329 
66 289  01/04/2023  10 133 599  10 133 599  2 081 
80 115  01/04/2024  12 247 180  12 247 180 
188 724  28 850 237  28 850 237  5 314  40 447  20 219  7 193 414 
PA Koppeschaar  01/04/2021  50 701  25 346  177.96  9 022 750  15/04/2021 
01/04/2021  2 464  1 643  821  174.39  286 523  23/09/2021 
54 310  01/04/2022  8 302 370  8 302 370  1 705 
85 072  01/04/2023  13 004 957  13 004 957  2 670 
49 954  01/04/2024  7 636 468  7 636 468 
189 336  28 943 795  28 943 795  6 839  52 344  26 167  9 309 273 
Prescribed officers 
V Balgobind  01/04/2021  21 434  10 714  177.96  3 814 395  15/04/2021 
01/04/2021  1 042  695  347  174.39  121 201  23/09/2021 
22 938  01/04/2022  3 506 532  3 506 532  720 
35 930  01/04/2023  5 492 619  5 492 619  1 128 
20 503  01/04/2024  3 134 294  3 134 294 
79 371  12 133 445  12 133 445  2 890  22 129  11 061  3 935 596 
AS De Angelis  01/04/2021  9 954  4 976  177.96  1 771 414  15/04/2021 
01/04/2021  13 000  1 084  177.96  2 313 480  15/04/2021 
01/04/2021  457  422  35  174.39  73 593  23/09/2021 
01/04/2021  484  323  161  174.39  56 328  23/09/2021 
10 702  01/04/2022  1 636 015  1 636 015  336 
33 410  01/04/2023  5 107 387  5 107 387  1 049 
19 066  01/04/2024  2 914 619  2 914 619 
63 178  9 658 021  9 658 021  2 326  23 699  6 256  4 214 815 
JG Meyer  01/04/2021  26 482  13 238  177.96  4 712 737  15/04/2021 
01/04/2021  1 287  859  428  174.39  149 801  23/09/2021 
28 209  01/04/2022  4 312 310  4 312 310  886 
44 185  01/04/2023  6 754 561  6 754 561  1 387 
25 214  01/04/2024  3 854 464  3 854 464 
97 608  14 921 335  14 921 335  3 560  27 341  13 666  4 862 538 
MI Mthenjane  01/04/2021  25 318  12 657  177.96  4 505 591  15/04/2021 
01/04/2021  1 231  821  410  174.39  143 174  23/09/2021 
26 589  01/04/2022  4 064 660  4 064 660  835 
41 649  01/04/2023  6 366 883  6 366 883  1 308 
23 767  01/04/2024  3 633 261  3 633 261 
92 005  14 064 804  14 064 804  3 374  26 139  13 067  4 648 765 
AT Ndoni  12 165  01/11/2024  1 859 664  1 859 664 
12 165  1 859 664  1 859 664 
M Veti  01/04/2021  24 972  12 483  177.96  4 444 017  15/04/2021 
01/04/2021  1 214  810  404  174.39  141 256  23/09/2021 
26 226  01/04/2022  4 009 169  4 009 169  824 
41 080  01/04/2023  6 279 900  6 279 900  1 290 
23 442  01/04/2024  3 583 579  3 583 579 
90 748  13 872 648  13 872 648  3 328  25 782  12 887  4 585 273 
1 Option strike price is nil.
2 Based on a share price of R152.87 which prevailed on 31 December 2021.
3 Shares forfeited due to performance conditions not being fully met.

Management share scheme – DBP

2022 Rights  
held at  
31 December1
Number  
Exercisable
period
Proceeds if  
exercisable at  
31 December2
R  
Pre-tax  
gain if  
exercisable at  
31 December2
R  
MSR  
election3
Number  
Options
exercised
during
the year
Number
Shares  
forfeited4
Number  
Sale price/
market price
R
Pre-tax
gain
R
Date
exercised
Executive directors
MDM Mgojo   15/03/2022       1 460   209.58 305 987 16/03/2022
  31/03/2022       8 618   212.89 1 834 686 31/03/2022
  31/03/2023       10 206 2 916 219.76 2 242 871 22/08/2022
  31/08/2023       842 477 219.76 185 038 22/08/2022
  19/03/2024       385 482 219.76 84 608 22/08/2022
  31/03/2024       4 031 5 039 219.76 885 853 22/08/2022
  21/09/2024       274 714 219.76 60 214 22/08/2022
  04/03/2025       270 2 161 219.76 59 335 22/08/2022
  31/03/2025       661 5 289 219.76 145 261 22/08/2022
        26 747 17 078 5 803 853
Dr N Tsengwa   15/03/2022       536   209.58 112 335 24/03/2022
  31/03/2022       2 436   212.89 518 600 04/04/2022
432 31/08/2023 93 878 93 878  
589 19/03/2024 127 996 127 996  
2 770 31/03/2024 601 949 601 949  
3 791 823 823 823 823   2 972 630 935
PA Koppeschaar   31/03/2022       5 543   212.89 1 180 049 31/03/2022
4 778 31/03/2023 1 038 307 1 038 307  
1 004 31/08/2023 218 179 218 179  
750 21/09/2024 162 983 162 983  
1 024 04/03/2025 222 525 222 525  
7 556 1 641 994 1 641 994   5 543 1 180 049
Prescribed officers
V Balgobind   15/03/2022       363   209.58 76 078 22/03/2022
  31/03/2022       2 623   212.89 558 410 31/03/2022
  31/03/2023         2 241
  21/09/2024         244
  04/03/2025         1 077
  31/03/2025         1 982
        2 986 5 544 634 488
H Bhola   15/03/2022       227   209.58 47 575 24/03/2022
  31/03/2022       718   212.89 152 855 06/04/2022
1 110 31/03/2023 241 214 241 214  
137 19/03/2024 29 771 29 771  
778 31/03/2024 169 067 169 067  
159 31/08/2024 34 552 34 552  
394 04/03/2025 85 620 85 620  
584 31/03/2025 126 909 126 909  
3 162 687 133 687 133   945   200 430
AS De Angelis 1 092 31/03/2023 237 303 237 303
466 31/08/2023 101 266 101 266
202 19/03/2024 43 897 43 897
1 269 31/03/2024 275 766 275 766
227 21/09/2024 49 329 49 329
3 256 707 561 707 561      
L Groenewald   15/03/2022       589   209.58 123 443 16/03/2022
  31/03/2022       2 338   212.89 497 737 08/04/2022
3 655 31/03/2023 794 268 794 268  
552 31/08/2023 119 955 119 955  
200 19/03/2024 43 462 43 462  
1 275 31/03/2024 277 070 277 070  
409 21/09/2024 88 880 88 880  
1 004 04/03/2025 218 179 218 179  
1 845 31/03/2025 400 937 400 937  
8 940 1 942 751 1 942 751   2 927 621 180
JG Meyer 4 942 31/03/2023 1 073 946 1 073 946
301 21/09/2024 65 410 65 410
5 243 1 139 356 1 139 356      
AT Ndoni 96 04/03/2025 20 862 20 862
96 20 862 20 862      
M Veti   15/03/2022     433
  31/03/2022     1 730
682 31/08/2023 148 205 148 205  
449 19/03/2024 97 572 97 572  
3 180 31/03/2024 691 046 691 046  
278 21/09/2024 60 412 60 412  
4 589 997 235 997 235 2 163    
1 Option strike price is nil.
2 Based on a share price of R217.31 which prevailed on 31 December 2022.
3 Election to transfer shares arising from the vested options to the MSR portfolio.
4 Shares forfeited due to performance conditions not being fully met.
2021 Rights 
held at 
31 December1
Number 
Exercisable
period
Proceeds if  
exercisable at  
31 December2
R  
Pre-tax  
gain if  
exercisable at  
31 December2
R  
Modification during
the year
Number
Options
exercised
during
the year
Number
Sale price/
market price
R
Pre-tax
gain
R
Date
exercised
Executive directors
MDM Mgojo 09/03/2021 4 372 177.96 778 041 13/04/2021
09/03/2021 142 142 174.39 24 763 23/09/2021
31/03/2021 11 139 177.96 1 982 296 13/04/2021
31/03/2021 361 361 174.39 62 955 23/09/2021
31/08/2021 33 1 036 174.39 180 668 01/10/2021
1 460 15/03/2022 223 190 223 190 46
8 618 31/03/2022 1 317 434 1 317 434 271
13 122 31/03/2023 2 005 960 2 005 960 412
1 319 31/08/2023 201 636 201 636 42
867 19/03/2024 132 538 132 538
9 070 31/03/2024 1 386 531 1 386 531
988 21/09/2024 151 036 151 036
35 444 5 418 325 5 418 325 1 307 17 050 3 028 723
Dr N Tsengwa 31/08/2021 9 274 174.39 47 783 01/10/2021
536 15/03/2022 81 938 81 938 17
2 436 31/03/2022 372 391 372 391 77
432 31/08/2023 66 040 66 040 14
589 19/03/2024 90 040 90 040
2 770 31/03/2024 423 450 423 450
6 763 1 033 859 1 033 859 117 274 47 783
PA Koppeschaar 31/08/2021 24 756 174.39 131 839 27/09/2021
5 543 31/03/2022 847 358 847 358 174
4 778 31/03/2023 730 413 730 413 150
1 004 31/08/2023 153 481 153 481 32
750 21/09/2024 114 653 114 653
12 075 1 845 905 1 845 905 380 756 131 839
Prescribed officers
V Balgobind 09/03/2021 1 089 177.96 193 798 16/04/2021
09/03/2021 36 36 174.39 6 278 23/09/2021
31/03/2021 1 880 177.96 334 565 15/04/2021
31/03/2021 61 61 174.39 10 638 23/09/2021
31/08/2021 9 262 174.39 45 690 01/10/2021
363 15/03/2022 55 492 55 492 12
2 623 31/03/2022 400 978 400 978 83
2 241 31/03/2023 342 582 342 582 71
244 21/09/2024 37 300 37 300
5 471 836 352 836 352 272 3 328 590 969
AS De Angelis 1 092 31/03/2023 166 934 166 934 35
466 31/08/2023 71 237 71 237 15
202 19/03/2024 30 880 30 880
1 269 31/03/2024 193 992 193 992
227 21/09/2024 34 701 34 701
3 256 497 744 497 744 50
JG Meyer 4 942 31/03/2023 755 484 755 484 156
301 21/09/2024 46 014 46 014  
5 243 801 498 801 498 156
MI Mthenjane 09/03/2021 1 346 177.96 239 534 13/04/2021
09/03/2021 44 44 174.39 7 673 23/09/2021
31/03/2021 2 331 177.96 414 825 13/04/2021
31/03/2021 76 76 174.39 13 254 23/09/2021
120 3 797 675 286
M Veti 09/03/2021 1 326 177.96 235 975 13/04/2021
09/03/2021 43 43 174.39 7 499 23/09/2021
31/03/2021 2 314 177.96 411 799 13/04/2021
31/03/2021 75 75 174.39 13 079 23/09/2021
31/08/2021 10 312 174.39 54 410 01/10/2021
433 15/03/2022 66 193 66 193 14
1 730 31/03/2022 264 465 264 465 55
682 31/08/2023 104 257 104 257 22
449 19/03/2024 68 639 68 639
3 180 31/03/2024 486 127 486 127
278 21/09/2024 42 498 42 498
6 752 1 032 179 1 032 179 219 4 070 722 762
1 Option strike price is nil.
2 Based on a share price of R152.87 which prevailed on 31 December 2021.

MSR portfolio shares

2022 Rights
held at
31 December
Number
Exercisable
period
Proceeds if  
exercisable at  
31 December1
R  
Pre-tax gain if  
exercisable at  
31 December1
R  
MSR election
during
the year
Number
Prescribed officers
AS De Angelis 1 638 30/06/2026 355 954  355 954  1 638
1 638 355 954  355 954  1 638
JG Meyer 10 796 30/06/2026 2 346 079  2 346 079  10 796
10 796 2 346 079  2 346 079  10 796
MI Mthenjane 2 035 30/06/2026 442 226  442 226  2 035
2 035 442 226  442 226  2 035
M Veti 2 163 30/06/2026 470 042  470 042  2 163
2 163 470 042  470 042  2 163
1 Based on a share price of R217.31 which prevailed on 31 December 2022.
Report SelectorReport Index
X

Generate your own report

You can create your own custom PDF version of the report.

Select your areas of interest from the list below and submit your selection to create a PDF ready for you to download.

CHAPTER 1: THE YEAR IN BRIEF
Add section
The year in brief

CHAPTER 2: REPORTS
Add section
2.1 Responsibility statement on internal financial controls
2.2 Directors' approval
2.3 Certificate by the group company secretary
2.4 Report of the directors
2.5 Audit committee report
2.6 Independent auditor's report

CHAPTER 3: SEGMENTAL REPORTING
Add section
3.1 Accounting policy relating to segmental reporting
3.2 Significant judgements and assumptions made by management in applying the related accounting policy
3.3 Reportable segments
3.4 Geographic location of segment assets

CHAPTER 4: FINANCIAL STATEMENTS
Add section
4.1.1 Group financial statements of comprehensive income
4.1.2 Group financial statements of financial position
4.1.3 Group financial statements of changes in equity
4.1.4 Group financial statements of cash flows
4.2.1 Company financial statement of comprehensive income
4.2.2 Company financial statement of financial position
4.2.3 Company financial statement of changes in equity
4.2.4 Company financial statement of cash flows

CHAPTER 5: EARNINGS
Add section
5.1 Accounting policy relating to earnings
5.2 Attributable earnings per share
5.3 Reconciliation of headline earnings
5.4 Headline earnings per share
5.5 Dividend distributions
5.6 Notes to the statements of cash flows relating to earnings
CHAPTER 6: OPERATIONAL PERFORMANCE AND WORKING CAPITAL
Add section
6.1 Operational performance
6.2 Working capital
6.3 Notes to the statements of cash flows relating to operational performance and working capital

CHAPTER 7: TAXATION
Add section
7.1 Accounting policies relating to taxation
7.2 Significant judgements and assumptions made by management in applying the related accounting policies
7.3 Income tax (expense)/benefit
7.4 Reconciliation of tax rates
7.5 Deferred tax
7.6 Notes to the statements of cash flows relating to taxation
7.7 Tax effect of other comprehensive income

CHAPTER 8: BUSINESS ENVIRONMENT AND PORTFOLIO CHANGES
Add section
8.1 Accounting policies relating to business environment and portfolio changes
8.2 Significant judgements and assumptions made by management in applying the related accounting policies
8.3 Disposals of subsidiaries
8.4 Impairment charges of non-current assets

CHAPTER 9: ASSOCIATES AND JOINT ARRANGEMENTS
Add section
9.1 Accounting policies relating to investments in associates and joint arrangements
9.2 Significant judgements and assumptions made by management in applying the related accounting policies
9.3 Income from investments in associates and joint ventures
9.4 Investments in associates and joint arrangements
9.5 Movement analysis of investments in associates and joint ventures
9.6 Summarised financial information of associates and joint ventures
9.7 Reconciliation of carrying amounts of investments in associates and joint ventures

CHAPTER 10: ASSETS
Add section

10.1 Property, plant and equipment
10.2 Intangible assets
10.3 Financial assets
10.4 Other assets

CHAPTER 11: LEASES
Add section
11.1 Accounting policies relating to leases
11.2 Judgements and assumptions made by management in applying the related accounting policies
11.3 Right-of-use assets
11.4 Lease liabilities

CHAPTER 12: FUNDING
Add section
12.1 Debt
12.2 Equity

CHAPTER 13: PROVISIONS AND CONTINGENCIES
Add section
13.1 Accounting policies relating to provisions and contingencies
13.2 Significant judgements and assumptions made by management in applying the related accounting policies
13.3 Provisions
13.4 Contingent liabilities and contingent assets

CHAPTER 14: PEOPLE
Add section
14.1 Accounting policies relating to employee benefits
14.2 Significant judgements and assumptions made by management in applying the related accounting policies
14.3 Employee benefits
14.4 Retirement employee obligations
14.5 Directors' and prescribed officers' remuneration

CHAPTER 15: RELATED PARTIES
Add section
15.1 Related-party transactions

CHAPTER 16: FINANCIAL INSTRUMENTS
Add section

16.1 Accounting policies relating to financial instruments
16.2 Judgements and assumptions made by management in applying the related accounting policies
16.3 Financial instruments

CHAPTER 17: SUBSIDIARIES
Add section
17.1 Accounting policies relating to subsidiaries
17.2 Significant judgements and assumptions made by management in applying the related accounting policies
17.3 Transactions with subsidiaries
17.4 Summary of investments in subsidiaries
17.5 Summary of indebtedness by/(to) subsidiaries
17.6 Detailed analysis of investments in subsidiaries
17.7 Non-controlling interests

CHAPTER 18: COMPLIANCE
Add section
18.1 Basis of preparation
18.2 Adoption of new, amended and revised standards and interpretations
18.3 Events after the reporting period

CHAPTER 19: ANNEXURES
Add section
Annexure 1 Shareholder analysis
Annexure 2 Definitions
Annexure 3 Administration
Annexure 4 Shareholders' diary

ACRONYMS
Add section
Acronyms